Turbocharging Phenotypic Screening with AI to Target mRNA Biology

My interview with Yochi Slonim, co-founder of Israeli-based Anima Biotech, about RNA-targeting small molecule therapeutics

While the pharmaceutical world is investigating biologics or mRNA-based therapies, Yochi Slonim, Israeli technology and biotech entrepreneur and public speaker on the subject of startup building and positioning, is sticking to the classics -- small molecules -- but his strategy comes with a twist.

Yochi is not a classically trained pharmaceutical scienti…